Larimar Therapeutics, Inc. (LRMR) Stock Total Returns
Growth of $10,000 chart
2021-04-21 to 2026-04-21 to
$
%
%
Loading chart…
Investment Performance
Final Value
$4,251
Total Return
-57.49%
CAGR
-15.73%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | +2.15% |
| Median | -1.83% |
| Best | +215.44% |
| Worst | -62.95% |
| % of Windows Positive | 47.2% |
1-Year (252 Trading Days)
| Average | +6.55% |
| Median | -3.85% |
| Best | +284.66% |
| Worst | -85.22% |
| % of Windows Positive | 47.6% |
3-Year (756 Trading Days)
| Average | -11.83% |
| Median | -22.71% |
| Best | +143.12% |
| Worst | -67.46% |
| % of Windows Positive | 31.5% |
Risk Metrics
| Maximum Drawdown | -89.87% |
| Average Drawdown | -62.87% |
| Drawdown Duration | 1231 Trading Days (Unrecovered) |
| Sortino Ratio | 0.51 |
| Calmar Ratio | -0.17 |
| CVaR (5%) | -12.80% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | +19.95% (+81.95% ann.) | +$1994.90 | $0.00 | $0.00 | $0.00 |
| 2025 | -1.55% | $154.94 | $0.00 | $0.00 | $0.00 |
| 2024 | -14.94% | $1494.43 | $0.00 | $0.00 | $0.00 |
| 2023 | +10.17% | +$1016.87 | $0.00 | $0.00 | $0.00 |
| 2022 | -61.72% | $6172.38 | $0.00 | $0.00 | $0.00 |
| 2021 | -49.60% | $4960.37 | $0.00 | $0.00 | $0.00 |
| 2020 | +60.74% | +$6073.52 | $0.00 | $0.00 | $0.00 |
| 2019 | -77.58% | $7757.56 | $0.00 | $0.00 | $0.00 |
| 2018 | +7.14% | +$714.29 | $0.00 | $0.00 | $0.00 |
| 2017 | +45.28% | +$4528.27 | $0.00 | $0.00 | $0.00 |
| 2016 | -49.44% | $4944.35 | $0.00 | $0.00 | $0.00 |
| 2015 | -79.60% | $7960.44 | $0.00 | $0.00 | $0.00 |
| 2014 partial | +56.15% (+130.42% ann.) | +$5615.19 | $0.00 | $0.00 | $0.00 |
Market Regimes
about| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | June 19, 2014 – February 19, 2020 | -93.62% | -38.45% | $9362.03 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -38.80% | -99.63% | $3880.01 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | +90.49% | +182.05% | +$9048.97 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | -55.21% | -53.32% | $5520.73 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -67.79% | -69.97% | $6779.19 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | +121.82% | +53.70% | +$12181.57 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – April 21, 2026 | -33.28% | -22.50% | $3328.37 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.